Cyber threat detection provider Intezer this week announced it has raised $15 million in a Series B funding round.
The New York-based cyber-security company helps organizations detect threats by revealing the “genetic” origins of software code, and also provides context on how to respond to incidents.
Intezer’s Genetic Malware Analysis technology takes an approach to detection by aiming to identify the origins of attacks. This, the company argues, should make it exponentially harder for attackers to conduct successful campaigns.
The new funding, Intezer CEO and Co-founder Itai Tevet says, will be used to accelerate sales growth and expand into the threat protection market.
The cyber-security company provides threat detection to a broad range of organizations, ranging from Fortune 500 companies to modern startups, and government agencies.
In 2019, Intezer uncovered many cyber threats and reported an increase in Linux and cloud-focused attacks. Some of these discoveries include crypto-miners, botnets, ransomware, and state-sponsored threats, such as HiddenWasp, QNAPCrypt, and PureLocker.
Last week, the company unveiled Intezer Protect, a new runtime cloud security product based on its core technology. Intezer also appointed industry veteran and former CyberArk CRO Ron Zoran to its board of directors.
The new funding round was led by OpenView and also saw investment from Intel Capital, Magma, and Samsung NEXT. Alon Cohen, founder and former CEO of CyberArk and co-founder of Intezer, also participated.
“While Genetic Malware Analysis is a relatively new category, we’ve seen more vendors incorporating this approach into their cybersecurity solutions. This new financing round will enable Intezer to strengthen its market leadership and product offerings to accelerate the global market adoption of Genetic Malware Analysis,” Cohen commented.
Related: Snyk Is Latest Cybersecurity Unicorn After Adding $150 Million in Funding
Related: Trusona Raises $20 Million in Series C Funding Round
Related: Detectify Raises $23.7 Million in Series B Funding Round
